Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
HeartBeam, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BEAT
Nasdaq
3840
www.heartbeam.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for HeartBeam, Inc.
HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
- Feb 13th, 2026 1:30 pm
HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer
- Jan 22nd, 2026 1:00 pm
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
- Jan 22nd, 2026 5:00 am
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup
- Jan 9th, 2026 1:40 pm
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference
- Jan 5th, 2026 12:30 pm
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
- Jan 5th, 2026 5:00 am
HeartBeam (BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation
- Dec 18th, 2025 1:00 pm
BC-Most Active Stocks
- Dec 12th, 2025 8:30 am
Sector Update: Health Care Stocks Climb Late Afternoon
- Dec 10th, 2025 1:58 pm
HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
- Dec 10th, 2025 1:30 pm
Top Midday Gainers
- Dec 10th, 2025 12:30 pm
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
- Dec 10th, 2025 5:00 am
HeartBeam (BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software
- Dec 1st, 2025 12:30 pm
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application
- Nov 26th, 2025 2:32 pm
Sector Update: Health Care Stocks Gain Friday Afternoon
- Nov 21st, 2025 11:38 am
HeartBeam (BEAT) Poised in the Future of Cardiac Care With Breakthrough Technology
- Nov 20th, 2025 1:00 pm
HeartBeam (BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates
- Nov 14th, 2025 1:30 pm
HeartBeam Inc (BEAT) Q3 2025 Earnings Call Highlights: Innovations and Challenges in Cardiac Care
- Nov 13th, 2025 10:05 pm
HeartBeam Reports Third Quarter 2025 Results
- Nov 13th, 2025 2:01 pm
HeartBeam (BEAT) Recognized as a Top Global Innovator in Portable ECG Technology
- Nov 12th, 2025 12:30 pm
Scroll